BrainSee

BrainSee

Biotechnology Research

Together we postpone and prevent dementia

About us

BrainSee is a medical software designed to help physicians determine the prognosis of patients who have amnestic mild cognitive impairment (aMCI). BrainSee’s novel medical AI algorithm processes a patient’s MRI and cognitive scores and provides a score between 0 and 100 (lower is better) that helps doctors determine the patient’s likelihood of progression from mild cognitive impairment to Alzheimer’s dementia. BrainSee was designed and developed based on 40 years of cutting-edge neuroscience, artificial intelligence (AI), and thousands of real patient data. BrainSee algorithm processes the patient’s brain MRI scan, pulling critical information that is physiologically relevant to the brain tissue degeneration, and combines it with clinical cognitive test scores to provide a prognostic insight to the physician. Such insight helps doctors choose the best course of treatment or interventions.

Website
https://brainsee.ai/
Industry
Biotechnology Research
Company size
11-50 employees

Updates

Affiliated pages

Similar pages